Sector
- Biotech
- Healthcare
Research Coverage
- Immunic, Inc. (IMUX)
- Veru Inc. (VERU)
- Viking Therapeutics, Inc.
Biography
William Wood, Ph.D., is a
biotech equity research analyst at B. Riley Securities. He joined the firm in
2020 and is responsible for covering smid-cap biotech companies within the
cardiometabolic and neuroscience sectors. Prior to B. Riley Securities, he was
an Assistant Research Professor at the University of Connecticut in the
Department of Physiology and Neurobiology and worked at the University of
Virginia. He earned his Ph.D. in cell biology from the University of
Connecticut, focusing on musculoskeletal development, where he also conducted
his postdoctoral training focusing on glial development. He received his B.S.
from Davidson College.